Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 4/2015

01-04-2015 | Letter to the Editor

Response to the letter by Brotherton regarding “Insoluble fiber and intestinal microbiota metabolism”

Authors: Jason R. Goldsmith, R. Balfour Sartor

Published in: Journal of Gastroenterology | Issue 4/2015

Login to get access

Excerpt

The letter to the editor by Carol Brotherton raises the question of the interaction among insoluble fiber (specifically cellulose and wheat bran), the microbiome, and human disease. We agree that this is an interesting and poorly understood area worthy of review and appreciate her comments. However, the author of the letter misstates components of our review, as well the literature she cites. …
Literature
1.
Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014;49:785–98.CrossRefPubMed
2.
Chassard C, Delmas E, Robert C, et al. The cellulose-degrading microbial community of the human gut varies according to the presence or absence of methanogens. FEMS Microbiol Ecol. 2010;74:205–13.CrossRefPubMed
3.
Nyman M, Asp NG, Cummings J, et al. Fermentation of dietary fibre in the intestinal tract: comparison between man and rat. Br J Nutr. 1986;55:487–96.CrossRefPubMed
4.
Brotherton CS, Taylor AG, Bourguignon C, et al. A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn disease. Gastroenterol Nurs. 2014;37:206–16.CrossRefPubMed
5.
Yao JH, Han JC, Wu SY, et al. Supplemental wheat bran and microbial phytase could replace inorganic phosphorus in laying hen diets. Czech J Anim Sci. 2007;52:407–13.
6.
Zaborin A, Smith D, Garfield K, et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio. 2014;5:e01361–414.CrossRefPubMedCentralPubMed
7.
Govers MJ, Gannon NJ, Dunshea FR, et al. Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs. Gut. 1999;45:840–7.CrossRefPubMedCentralPubMed
Metadata
Title
Response to the letter by Brotherton regarding “Insoluble fiber and intestinal microbiota metabolism”
Authors
Jason R. Goldsmith
R. Balfour Sartor
Publication date
01-04-2015
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 4/2015
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-015-1044-5

Other articles of this Issue 4/2015

Journal of Gastroenterology 4/2015 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Comparison study of immunohistochemical staining for the diagnosis of type 1 autoimmune pancreatitis

Original Article—Alimentary Tract

Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers

Original Article—Alimentary Tract

Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection

Original Article—Liver, Pancreas, and Biliary Tract

Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis

Original Article—Alimentary Tract

Food antigen-induced immune responses in Crohn’s disease patients and experimental colitis mice

Review

Small bowel injury in low-dose aspirin users
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits